0
0

Chapter 7. Psychoneuroendocrinology

Ania Korszun, Ph.D., M.D., M.R.C.Psych.; Josephine Astrid Archer, B.Sc.; Elizabeth Ann Young, M.D.
DOI: 10.1176/appi.books.9781585623860.417048

Sections

Excerpt

An association between hormones and psychiatric disorders has been long recognized, but it is only in the past few decades that we have reached an understanding of the mechanisms underlying this association. A full account of the myriad ways in which the various endocrine systems influence neurobehavioral function would be beyond the scope of a single chapter. We will therefore focus on examples of promising research directions in this area: namely, how the stress and reproductive hormone axes contribute to the pathoetiology of psychiatric conditions, in particular mood and anxiety disorders.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

FIGURE 7–1. The hypothalamic-pituitary-adrenal axis.ACTH = adrenocorticotropic hormone; CRH = corticotropin-releasing hormone; FSH = follicle-stimulating hormone; GnRH = gonadotropin-releasing hormone; LH = luteinizing hormone.

FIGURE 7–2. Effects of the hypothalamic-pituitary-adrenal axis on the hypothalamic-pituitary-gonadal axis.GH = growth hormone; GHIH = growth hormone–inhibiting hormone; GHRH = growth hormone–releasing hormone; IGF-1 = insulin-like growth factor 1.

References

Abelson JL, Curtis GC: Hypothalamic-pituitary-adrenal axis activity in panic disorder: 24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 53:323–331, 1996
[PubMed]
 
Abelson JL, Glitz D, Cameron OG, et al: Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. Arch Gen Psychiatry 48:157–162, 1991
[PubMed]
 
Abelson JL, Glitz D, Cameron OG, et al: Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder. Biol Psychiatry 32:18–25, 1992
[PubMed]
 
Amsterdam JD, Maislin G: Comparison of growth hormone response after clonidine and insulin hypoglycemia in affective illness. Biol Psychiatry 28:308–314, 1990
[PubMed]
 
Amsterdam JD, Winokur A, Abelman E, et al: Cosyntropin (ACTH alpha 1–24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry 140:907–909, 1983
[PubMed]
 
Amsterdam JD, Maislin G, Skolnick B, et al: Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers. Biol Psychiatry 26:265–278, 1989
[PubMed]
 
Angold A, Costello EJ, Erkanli A, et al: Pubertal changes in hormone levels and depression in girls. Psychol Med 29:1043–1053, 1999
[PubMed]
 
Anisman H, Griffiths J, Matheson K, et al: Posttraumatic stress symptoms and salivary cortisol levels. Am J Psychiatry 158:1509–1511, 2001
[PubMed]
 
Atmaca M, Kuloglu M, Tezcan E, et al: Neopterin levels and dexamethasone suppression test in posttraumatic stress disorder. Eur Arch Psychiatry Clin Neurosci 252:161–165, 2002
[PubMed]
 
Belchetz PE, Plant TM, Nakai Y, et al: Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 202:631–633, 1978
[PubMed]
 
Berga SL, Mortola JF, Girton L, et al: Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 68:301–308, 1989
[PubMed]
 
Berger M, Pirke KM, Doerr P, et al: Influence of weight loss on the dexamethasone suppression test. Arch Gen Psychiatry 40:585–586, 1983
[PubMed]
 
Bethea CL, Lu NZ, Gundlah C, et al: Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23:41–100, 2002
[PubMed]
 
Bhagwagar Z, Hafizi S, Cowen PJ: Increase in concentration of waking salivary cortisol in recovered patients with depression. Am J Psychiatry 160:1890–1891, 2003
[PubMed]
 
Biller BM, Federoff HJ, Koenig JI, et al: Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 70:311–317, 1990
[PubMed]
 
Boscarino JA: Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: findings and clinical implications. J Consult Clin Psychol 64:191–201, 1996
[PubMed]
 
Brambilla F, Maggioni M, Ferrari E, et al: Tonic and dynamic gonadotropin secretion in depressive and normothymic phases of affective disorders. Psychiatry Res 32:229–239, 1990
[PubMed]
 
Brambilla F, Bellodi L, Perna G, et al: Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology 26:12–22, 1992
[PubMed]
 
Breen KM, Stackpole CA, Clarke IJ, et al: Does the type II glucocorticoid receptor mediate cortisol-induced suppression in pituitary responsiveness to gonadotropin-releasing hormone? Endocrinology 145:2739–2746, 2004
[PubMed]
 
Bremner JD, Vythilingam M, Vermetten E, et al: Cortisol response to a cognitive stress challenge in posttraumatic stress disorder (PTSD) related to childhood abuse. Psychoneuroendocrinology 28:733–750, 2003
[PubMed]
 
Breslau N, Davis GC, Andreski P, et al: Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 48:216–222, 1991
[PubMed]
 
Breslau N, Davis GC, Andreski P: Risk factors for PTSD-related traumatic events: a prospective analysis. Am J Psychiatry 152:529–535, 1995
[PubMed]
 
Cameron OG, Abelson JL, Young EA: Anxious and depressive disorders and their comorbidity: effect on central nervous system noradrenergic function. Biol Psychiatry 56:875–883, 2004
[PubMed]
 
Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression, I: limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 33:1039–1044, 1976
[PubMed]
 
Carroll BJ, Feinberg M, Greden JF, et al: A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15–22, 1981
[PubMed]
 
Casanueva FF, Borras CG, Burguera B, et al: Steroids and neuroendocrine function in anorexia nervosa. J Steroid Biochem 27:635–640, 1987
[PubMed]
 
Chabbert BN, Djakoure C, Maitre SC, et al: Regulation of the human menstrual cycle. Front Neuroendocrinol 19:151–186, 1998
 
Chan AF, Mortola JF, Wood SH, et al: Persistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486. Obstet Gynecol 84:1001–1005, 1994
[PubMed]
 
Charney DS, Heninger GR: Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 43:1042–1054, 1986
[PubMed]
 
Charney DS, Heninger GR, Sternberg DE, et al: Adrenergic receptor sensitivity in depression: effects of clonidine in depressed patients and healthy subjects. Arch Gen Psychiatry 39:290–294, 1982
[PubMed]
 
Checkley SA, Slade AP, Shur E: Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 138:51–55, 1981
[PubMed]
 
Checkley SA, Glass IB, Thompson C, et al: The GH response to clonidine in endogenous as compared with reactive depression. Psychol Med 14:773–777, 1984
[PubMed]
 
Christian JJ: Population density and reproductive efficiency. Biol Reprod 4:248–294, 1971
[PubMed]
 
Cohen LS, Soares CN, Vitonis AF, et al: Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63:385–390, 2006
[PubMed]
 
Copeland KC, Underwood LE, Van Wyk JJ: Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. J Clin Endocrinol Metab 50:690–697, 1980
[PubMed]
 
Coplan JD, Rosenblum L, Friedman S, et al: Noradrenergic/serotonergic interaction in panic disorder. Presented at the 13th National Conference of the Anxiety Disorders Association of America, Charleston, SC, March 19–21, 1993
 
Coplan JD, Moreau D, Chaput F, et al: Salivary cortisol concentrations before and after carbon-dioxide inhalations in children. Biol Psychiatry 51:326–333, 2002
[PubMed]
 
Corn TH, Hale AS, Thompson C, et al: A comparison of the growth hormone responses to clonidine and apomorphine in the same patients with endogenous depression. Br J Psychiatry 144:636–639, 1984
[PubMed]
 
Corsello SM, Tofani A, Della CS, et al: Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion. Acta Endocrinol (Copenh) 126:113–116, 1992
[PubMed]
 
Cox JL, Connor Y, Kendell RE: Prospective study of the psychiatric disorders of childbirth. Br J Psychiatry 140:111–117, 1982
[PubMed]
 
Curtis GC, Cameron OG, Nesse RM: The dexamethasone suppression test in panic disorder and agoraphobia. Am J Psychiatry 139:1043–1046, 1982
[PubMed]
 
Curtis GC, Abelson JL, Gold PW: Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment. Biol Psychiatry 41:76–85, 1997
[PubMed]
 
Davidson LM, Baum A: Chronic stress and posttraumatic stress disorders. J Consult Clin Psychol 54:303–308, 1986
[PubMed]
 
Debus N, Breen KM, Barrell GK, et al: Does cortisol mediate endotoxin-induced inhibition of pulsatile luteinizing hormone and gonadotropin-releasing hormone secretion? Endocrinology 143:3748–3758, 2002
[PubMed]
 
del Balzo P, Salvatori R, Cappa M, et al: Pyridostigmine does not reverse dexamethasone-induced growth hormone inhibition. Clin Endocrinol (Oxf) 33:605–612, 1990
 
Devesa J, Lima L, Lois N, et al: Reasons for the variability in growth hormone (GH) responses to GHRH challenge: the endogenous hypothalamic-somatotroph rhythm (HSR). Clin Endocrinol (Oxf) 30:367–377, 1989
[PubMed]
 
Devesa J, Arce V, Lois N, et al: Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men. J Clin Endocrinol Metab 71:1581–1588, 1990
[PubMed]
 
Devesa J, Diaz MJ, Tresguerres JA, et al: Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. J Clin Endocrinol Metab 73:251–256, 1991a
 
Devesa J, Lois N, Arce V, et al: The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans. J Steroid Biochem Mol Biol 40:165–173, 1991b
 
Devesa J, Lima L, Tresguerres JA: Neuroendocrine control of growth-hormone secretion in humans. Trends Endocrinol Metab 3:175–183, 1992
[PubMed]
 
diZerega GS, Hodgen GD: Folliculogenesis in the primate ovarian cycle. Endocr Rev 2:27–49, 1981
[PubMed]
 
Edelstein CK, Roy-Byrne P, Fawzy FI, et al: Effects of weight loss on the dexamethasone suppression test. Am J Psychiatry 140:338–341, 1983
[PubMed]
 
Elzinga BM, Schmahl CG, Vermetten E, et al: Higher cortisol levels following exposure to traumatic reminders in abuse-related PTSD. Neuropsychopharmacology 28:1656–1665, 2003
[PubMed]
 
Facchinetti F, Volpe A, Nappi G, et al: Impairment of adrenergic-induced proopiomelanocortin-related peptide release in heroin addicts. Acta Endocrinol (Copenh) 108:1–5, 1985
[PubMed]
 
Feder A, Coplan JD, Goetz RR, et al: Twenty-four-hour cortisol secretion patterns in prepubertal children with anxiety or depressive disorders. Biol Psychiatry 56:198–204, 2004
[PubMed]
 
Ferin M, Vande WR: Endogenous opioid peptides and the control of the menstrual cycle. Eur J Obstet Gynecol Reprod Biol 18:365–373, 1984
[PubMed]
 
Ford O, Lethaby A, Mol B, et al: Progesterone for premenstrual syndrome. Cochrane Database Syst Rev (4):CD003415, 2006
 
Freeman EW, Sammel MD, Liu L, et al: Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 61:62–70, 2004
[PubMed]
 
Freeman EW, Sammel MD, Lin H, et al: Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63:375–382, 2006
[PubMed]
 
Fukuda S, Morimoto K, Mure K, et al: Effect of the Hanshin-Awaji earthquake on posttraumatic stress, lifestyle changes, and cortisol levels of victims. Arch Environ Health 55:121–125, 2000
[PubMed]
 
Gambacciani M, Yen SS, Rasmussen DD: GnRH release from the mediobasal hypothalamus: in vitro inhibition by corticotropin-releasing factor. Neuroendocrinology 43:533–536, 1986
[PubMed]
 
Gann H, Riemann D, Stoll S, Berger, M, et al: Growth hormone response to growth hormone-releasing hormone and clonidine in depression. Biol Psychiatry 38:325–329, 1995
[PubMed]
 
Gerra G, Zaimovic A, Zambelli U, et al: Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology 42:82–92, 2000
[PubMed]
 
Ghigo E, Arvat E, Mazza E, et al: Failure of pyridostigmine to increase both basal and GHRH-induced GH secretion in the night. Acta Endocrinol (Copenh) 122:37–40, 1990
[PubMed]
 
Giustina A, Wehrenberg WB: The role of glucocorticoids in the regulation of growth-hormone secretion—mechanisms and clinical significance. Trends Endocrinol Metab 3:306–311, 1992
[PubMed]
 
Gold PW, Loriaux DL, Roy A, et al: Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: pathophysiologic and diagnostic implications. N Engl J Med 314:1329–1335, 1986
[PubMed]
 
Goodman RL, Karsch FJ: Pulsatile secretion of luteinizing hormone: differential suppression by ovarian steroids. Endocrinology 107:1286–1290, 1980
[PubMed]
 
Grambsch P, Young EA, Meller WH: Pulsatile luteinizing hormone disruption in depression. Psychoneuroendocrinology 29:825–829, 2004
[PubMed]
 
Gregoire AJ, Kumar R, Everitt B, et al: Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347:930–933, 1996
[PubMed]
 
Grunhaus L, Flegel P, Haskett RF, et al: Serial dexamethasone suppression tests in simultaneous panic and depressive disorders. Biol Psychiatry 22:332–338, 1987
[PubMed]
 
Halbreich U, Vital-Herne J, Goldstein S, et al: Sex differences in biological factors putatively related to depression. J Affect Disord 7:223–233, 1984
[PubMed]
 
Halbreich U, Asnis GM, Shindledecker R, et al: Cortisol secretion in endogenous depression, I: basal plasma levels. Arch Gen Psychiatry 42:904–908, 1985
[PubMed]
 
Halbreich U, Endicott J, Goldstein S, et al: Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 74:576–586, 1986
[PubMed]
 
Harlow BL, Wise LA, Otto MW, et al: Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 60:29–36, 2003
[PubMed]
 
Hawk LW, Dougall AL, Ursano RJ, et al: Urinary catecholamines and cortisol in recent-onset posttraumatic stress disorder after motor vehicle accidents. Psychosom Med 62:423–434, 2000
[PubMed]
 
Heim C, Newport DJ, Heit S, et al: Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284:592–597, 2000
[PubMed]
 
Heim C, Newport DJ, Bonsall R, et al: Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry 158:575–581, 2001
[PubMed]
 
Heninger GR: A biological perspective on comorbidity of major depressive disorder and panic disorder, in Comorbidity of Mood and Anxiety Disorders. Edited by Maser JD, Cloninger CR. Washington, DC, American Psychiatric Press, 1990, pp 381–401
 
Herman JP, Wiegand SJ, Watson SJ: Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Endocrinology 127:2408–2417, 1990
[PubMed]
 
Hlatky MA, Boothroyd D, Vittinghoff E, et al: Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA 287:591–597, 2002
[PubMed]
 
Ho KY, Evans WS, Blizzard RM, et al: Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51–58, 1987
[PubMed]
 
Hohtari H, Elovainio R, Salminen K, et al: Plasma corticotropin-releasing hormone, corticotropin, and endorphins at rest and during exercise in eumenorrheic and amenorrheic athletes. Fertil Steril 50:233–238, 1988
[PubMed]
 
Hohtari H, Salminen-Lappalainen K, Laatikainen T: Response of plasma endorphins, corticotropin, cortisol, and luteinizing hormone in the corticotropin-releasing hormone stimulation test in eumenorrheic and amenorrheic athletes. Fertil Steril 55:276–280, 1991
[PubMed]
 
Hollander E, DeCaria C, Nitescu A, et al: Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controls. Psychiatry Res 37:161–177, 1991
[PubMed]
 
Holsboer F, Von Bardeleben U, Gerken A, et al: Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 311:1127, 1984
[PubMed]
 
Holsboer F, Von Bardeleben U, Buller R, et al: Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res Suppl 16:80–88, 1987
[PubMed]
 
Hulse JA, Rosenthal SM, Cuttler L, et al: The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men. J Clin Endocrinol Metab 63:872–878, 1986
[PubMed]
 
Jacobson L, Akana SF, Cascio CS, et al: The adrenocortical system responds slowly to removal of corticosterone in the absence of concurrent stress. Endocrinology 124:2144–2152, 1989
[PubMed]
 
Jaffe RB, Plosker S, Marshall L, et al: Neuromodulatory regulation of gonadotropin-releasing hormone pulsatile discharge in women. Am J Obstet Gynecol 163(5 pt 2):1727–1731, 1990
 
Kanter ED, Wilkinson CW, Radant AD, et al: Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol Psychiatry 50:238–245, 2001
[PubMed]
 
Karsch FJ, Foster DL, Bittman EL, et al: A role for estradiol in enhancing luteinizing hormone pulse frequency during the follicular phase of the estrous cycle of sheep. Endocrinology 113:1333–1339, 1983
[PubMed]
 
Kasa-Vubu JZ, Sowers M, Ye W, et al: Differences in endocrine function with varying fitness capacity in postpubertal females across the weight spectrum. Arch Pediatr Adolesc Med 158:333–340, 2004
[PubMed]
 
Katona CL, Healy D, Paykel ES, et al: Growth hormone and physiological responses to clonidine in depression. Psychol Med 23:57–63, 1993
[PubMed]
 
Keller-Wood ME, Dallman MF: Corticosteroid inhibition of ACTH secretion. Endocr Rev 5:1–24, 1984
[PubMed]
 
Kellner M, Baker DG, Yassouridis A, et al: Mineralocorticoid receptor function in patients with posttraumatic stress disorder. Am J Psychiatry 159:1938–1940, 2002
[PubMed]
 
Kellner M, Yassouridis A, Hubner R, et al: Endocrine and cardiovascular responses to corticotropin-releasing hormone in patients with posttraumatic stress disorder: a role for atrial natriuretic peptide? Neuropsychobiology 47:102–108, 2003
[PubMed]
 
Kellner M, Otte C, Yassouridis A, et al: Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings. Eur Neuropsychopharmacol 14:337–339, 2004a
 
Kellner M, Schick M, Yassouridis A, et al: Metyrapone tests in patients with panic disorder. Biol Psychiatry 56:898–900, 2004b
 
Kendell RE: Emotional and physical factors in the genesis of puerperal mental disorders. J Psychosom Res 29:3–11, 1985
[PubMed]
 
Kessler RC, Sonnega A, Bromet E, et al: Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 52:1048–1060, 1995
[PubMed]
 
Klaiber EL, Broverman DM, Vogel W, et al: Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36:550–554, 1979
[PubMed]
 
Knobil E: The GnRH pulse generator. Am J Obstet Gynecol 163(5 pt 2):1721–1727, 1990
 
Krieger DT: Rhythms in CRH, ACTH and corticosteroids. Endocr Rev 1:123, 1979
 
Krishnan KR, Manepalli AN, Ritchie JC, et al: Growth hormone-releasing factor stimulation test in depression. Am J Psychiatry 145:90–92, 1988
[PubMed]
 
Krishnan KR, Ritchie JC, Saunders W, et al: Nocturnal and early morning secretion of ACTH and cortisol in humans. Biol Psychiatry 28:47–57, 1990a
 
Krishnan KR, Ritchie JC, Saunders WB, et al: Adrenocortical sensitivity to low-dose ACTH administration in depressed patients. Biol Psychiatry 27:930–933, 1990b
 
Kwak SP, Morano MI, Young EA, et al: Diurnal CRH mRNA rhythm in the hypothalamus: decreased expression in the evening is not dependent on endogenous glucocorticoids. Neuroendocrinology 57:96–105, 1993
[PubMed]
 
Lal S, Nair NP, Thavundayil JX, et al: Clonidine-induced growth hormone secretion in chronic schizophrenia. Acta Psychiatr Scand 68:82–88, 1983
[PubMed]
 
Lee MA, Cameron OG, Gurguis GN, et al: Alpha 2-adrenoreceptor status in obsessive-compulsive disorder. Biol Psychiatry 27:1083–1093, 1990
[PubMed]
 
Lemieux AM, Coe CL: Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom Med 57:105–115, 1995
[PubMed]
 
Lesch KP, Laux G, Erb A, et al: Growth hormone (GH) responses to GH-releasing hormone in depression: correlation with GH release following clonidine. Psychiatry Res 25:301–310, 1988
[PubMed]
 
Levin AP, Saoud JB, Strauman T, et al: Responses of generalized and discrete social phobics during public speaking. J Anxiety Disord 7:207–221, 1993
 
Liberzon I, Abelson JL, Flagel SB, et al: Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology 21:40–50, 1999
[PubMed]
 
Lindley SE, Carlson EB, Benoit M: Basal and dexamethasone suppressed salivary cortisol concentrations in a community sample of patients with posttraumatic stress disorder. Biol Psychiatry 55:940–945, 2004
[PubMed]
 
Linkowski P, Mendlewicz J, Leclercq R, et al: The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 61:429–438, 1985
[PubMed]
 
Loucks AB, Mortola JF, Girton L, et al: Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women. J Clin Endocrinol Metab 68:402–411, 1989
[PubMed]
 
MacLusky NJ, Naftolin F, Leranth C: Immunocytochemical evidence for direct synaptic connections between corticotropin-releasing factor (CRF) and gonadotrophin-releasing hormone (GnRH)-containing neurons in the preoptic area of the rat. Brain Res 439:391–395, 1988
[PubMed]
 
Maes M, Lin A, Bonaccorso S, et al: Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 98:328–335, 1998
[PubMed]
 
Mann DR, Jackson GG, Blank MS: Influence of adrenocorticotropin and adrenalectomy on gonadotropin secretion in immature rats. Neuroendocrinology 34:20–26, 1982
[PubMed]
 
Martel FL, Hayward C, Lyons DM, et al: Salivary cortisol levels in socially phobic adolescent girls. Depress Anxiety 10:25–27, 1999
[PubMed]
 
Mason JW, Giller EL, Kosten TR, et al: Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis 174:145–149, 1986
[PubMed]
 
Matussek N, Laakmann G: Growth hormone response in patients with depression. Acta Psychiatr Scand Suppl 290:122–126, 1981
[PubMed]
 
Matussek N, Ackenheil M, Hippius H, et al: Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 2:25–36, 1980
[PubMed]
 
Meller WH, Zander KM, Crosby RD, et al: Luteinizing hormone pulse characteristics in depressed women. Am J Psychiatry 154:1454–1455, 1997
[PubMed]
 
Meller WH, Grambsch PL, Bingham C, et al: Hypothalamic pituitary gonadal axis dysregulation in depressed women. Psychoneuroendocrinology 26:253–259, 2001
[PubMed]
 
Mendelson WB, Sitaram N, Wyatt RJ, et al: Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism. J Clin Invest 61:1683–1690, 1978
[PubMed]
 
Mendlewicz J, Linkowski P, Kerkhofs M, et al: Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metab 60:505–512, 1985
[PubMed]
 
Midgley AR Jr, Jaffe RB: Regulation of human gonadotropins, X: episodic fluctuation of LH during the menstrual cycle. J Clin Endocrinol Metab 33:962–969, 1971
[PubMed]
 
Mitchell P, Smythe G, Parker G, et al: Growth hormone and other hormonal responses to clonidine in melancholic and nonmelancholic depressed subjects and controls. Psychiatry Res 37:179–193, 1991
[PubMed]
 
Morris P, Hopwood M, Maguire K, et al: Blunted growth hormone response to clonidine in post-traumatic stress disorder. Psychoneuroendocrinology 29:269–278, 2004
[PubMed]
 
Morrison MF, Kallan MJ, Ten HT, et al: Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry 55:406–412, 2004
[PubMed]
 
Mortola JF, Girton L, Fischer U: Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 72:252A–252F, 1991
 
Muller EE: Neural control of somatotropic function. Physiol Rev 67:962–1053, 1987
[PubMed]
 
Newport DJ, Heim C, Bonsall R, et al: Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry 55:10–20, 2004
[PubMed]
 
Nikolarakis KE, Almeida OF, Herz A: Corticotropin-releasing factor (CRF) inhibits gonadotropin-releasing hormone (GnRH) release from superfused rat hypothalami in vitro. Brain Res 377:388–390, 1986a
 
Nikolarakis KE, Almeida OF, Herz A: Inhibition of LH release by CRF may be partially mediated through hypothalamic beta-endorphin release. NIDA Res Monogr 75:403–405, 1986b
 
Nutt DJ: Altered central alpha 2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 46:165–169, 1989
[PubMed]
 
O'Hara MW: Social support, life events, and depression during pregnancy and the puerperium. Arch Gen Psychiatry 43:569–573, 1986
[PubMed]
 
O'Hara MW, Schlechte JA, Lewis DA, et al: Prospective study of postpartum blues: biologic and psychosocial factors. Arch Gen Psychiatry 48:801–806, 1991
[PubMed]
 
Olster DH, Ferin M: Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab 65:262–267, 1987
[PubMed]
 
Penalva A, Gaztambide S, Vazquez JA, et al: Role of cholinergic muscarinic pathways on the free fatty acid inhibition of GH responses to GHRH in normal men. Clin Endocrinol (Oxf) 33:171–176, 1990
[PubMed]
 
Peters JR, Evans PJ, Page MD, et al: Cholinergic muscarinic receptor blockade with pirenzepine abolishes slow wave sleep-related growth hormone release in normal adult males. Clin Endocrinol (Oxf) 25:213–217, 1986
[PubMed]
 
Petraglia F, Sutton S, Vale W, et al: Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation. Endocrinology 120:1083–1088, 1987
[PubMed]
 
Pfohl B, Sherman B, Schlechte J, et al: Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 42:897–903, 1985
[PubMed]
 
Pirke KM, Schweiger U, Lemmel W, et al: The influence of dieting on the menstrual cycle of healthy young women. J Clin Endocrinol Metab 60:1174–1179, 1985
[PubMed]
 
Pitman RK, Orr SP: Twenty-four-hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder. Biol Psychiatry 27:245–247, 1990
[PubMed]
 
Plotsky PM: Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121:924–930, 1987
[PubMed]
 
Plotsky PM, Vale W: Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 230:461–463, 1985
[PubMed]
 
Plotsky PM, Cunningham ET Jr, Widmaier EP: Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 10:437–458, 1989
[PubMed]
 
Putnam CD, Brann DW, Mahesh VB: Acute activation of the adrenocorticotropin-adrenal axis: effect on gonadotropin and prolactin secretion in the female rat. Endocrinology 128:2558–2566, 1991
[PubMed]
 
Radovick S, Wondisford FE, Nakayama, Y, et al: Isolation and characterization of the human gonadotropin-releasing hormone gene in the hypothalamus and placenta. Mol Endocrinol 4:476–480, 1990
[PubMed]
 
Rasmusson AM, Lipschitz DS, Wang S, et al: Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol Psychiatry 50:965–977, 2001
[PubMed]
 
Reame N, Sauder SE, Kelch RP, et al: Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. J Clin Endocrinol Metab 59:328–337, 1984
[PubMed]
 
Reame NE, Sauder SE, Case GD, et al: Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation. J Clin Endocrinol Metab 61:851–858, 1985
[PubMed]
 
Reame NE, Marshall JC, Kelch RP: Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle. Psychoneuroendocrinology 17:205–213, 1992
[PubMed]
 
Reich T, Winokur G: Postpartum psychoses in patients with manic depressive disease. J Nerv Ment Dis 151:60–68, 1970
[PubMed]
 
Rivier C, Vale W: Influence of corticotropin-releasing factor on reproductive functions in the rat. Endocrinology 114:914–921, 1984
[PubMed]
 
Rivier C, Rivier J, Vale W: Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 231:607–609, 1986
[PubMed]
 
Roberts JL, Budarf ML, Baxter JD, et al: Selective reduction of proadrenocorticotropin/endorphin proteins and messenger ribonucleic acid activity in mouse pituitary tumor cells by glucocorticoids. Biochemistry 18:4907–4915, 1979
[PubMed]
 
Rosenbaum AH, Ginsberg K, Rosenberg R, et al: Treatment for major depression and manic-depressive illness with gonadotropin-releasing hormone agonist therapy (abstract). International Society of Psychoneuroendocrinology XXVIIth Congress, Cascais, Portugal, August 1996
 
Ross RJ, Tsagarakis S, Grossman A, et al: GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Clin Endocrinol (Oxf) 27:727–733, 1987
[PubMed]
 
Roy-Byrne PP, Uhde TW, Post RM, et al: The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896–899, 1986
[PubMed]
 
Rubin RT, Poland RE, Lesser IM, et al: Neuroendocrine aspects of primary endogenous depression, I: cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 44:328–336, 1987
[PubMed]
 
Rubinow DR, Schmidt PJ: Gonadal steroid regulation of mood: the lessons of premenstrual syndrome. Front Neuroendocrinol 27:210–216, 2006
[PubMed]
 
Rubinow DR, Hoban MC, Grover GN, et al: Changes in plasma hormones across the menstrual-cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 158:5–11, 1988
[PubMed]
 
Sachar EJ, Hellman L, Roffwarg HP, et al: Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 28:19–24, 1973
[PubMed]
 
Sakakura M, Takebe K, Nakagawa S: Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 40:774–779, 1975
[PubMed]
 
Santa Ana EJ, Saladin ME, Back SE, et al: PTSD and the HPA axis: differences in response to the cold pressor task among individuals with child vs. adult trauma. Psychoneuroendocrinology 31:501–509, 2006
 
Schittecatte M, Charles G, Depauw Y, et al: Growth hormone response to clonidine in panic disorder patients. Psychiatry Res 23:147–151, 1988
[PubMed]
 
Schittecatte M, Charles G, Machowski R, et al: Growth hormone response to clonidine in untreated depressed patients. Psychiatry Res 29:199–206, 1989
[PubMed]
 
Schittecatte M, Ansseau M, Charles G, et al: Growth hormone response to clonidine in male patients with panic disorder untreated by antidepressants. Psychol Med 22:1059–1062, 1992
[PubMed]
 
Schittecatte M, Charles G, Machowski R, et al: Effects of gender and diagnosis on growth hormone response to clonidine for major depression: a large-scale multicenter study. Am J Psychiatry 151:216–220, 1994
[PubMed]
 
Schmidt PJ, Nieman LK, Grover GN, et al: Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Engl J Med 324:1174–1179, 1991
[PubMed]
 
Schmidt PJ, Nieman LK, Danaceau MA, et al: Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338:209–216, 1998
[PubMed]
 
Schmidt PJ, Nieman L, Danaceau MA, et al: Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414–420, 2000
[PubMed]
 
Schwartz NB, Justo SN: Acute changes in serum gonadotrophins and steroids following orchidectomy in the rat: role of the adrenal gland. Endocrinology 100:1550–1556, 1977
[PubMed]
 
Schweiger U, Deuschle M, Weber B, et al: Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med 61:292–296, 1999
[PubMed]
 
Shapira B, Oppenheim G, Zohar J, et al: Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry 20:576–579, 1985
[PubMed]
 
Shibasaki T, Hotta M, Masuda A, et al: Plasma GH responses to GHRH and insulin-induced hypoglycemia in man. J Clin Endocrinol Metab 60:1265–1267, 1985
[PubMed]
 
Siever LJ, Uhde TW: New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol Psychiatry 19:131–156, 1984
[PubMed]
 
Siever LJ, Uhde TW, Silberman EK, et al: Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls. Psychiatry Res 6:171–183, 1982
[PubMed]
 
Smith MA, Davidson J, Ritchie JC, et al: The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry 26:349–355, 1989
[PubMed]
 
Soares CN, Almeida OP, Joffe H, et al: Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 58:529–534, 2001
[PubMed]
 
Soules MR, Steiner RA, Clifton DK, et al: Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab 58:378–383, 1984
[PubMed]
 
Soules MR, Steiner RA, Cohen NL, et al: Nocturnal slowing of pulsatile luteinizing hormone secretion in women during the follicular phase of the menstrual cycle. J Clin Endocrinol Metab 61:43–49, 1985
[PubMed]
 
Steele PA, Judd SJ: Role of endogenous opioids in reducing the frequency of pulsatile luteinizing hormone secretion induced by progesterone in normal women. Clin Endocrinol (Oxf) 25:669–674, 1986
[PubMed]
 
Stein MB, Yehuda R, Koverola C, et al: Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psychiatry 42:680–686, 1997
[PubMed]
 
Steingold KA, Cedars M, Lu JK, et al: Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. Obstet Gynecol 69(3 pt 1):403–411, 1987
 
Suh BY, Liu JH, Berga SL, et al: Hypercortisolism in patients with functional hypothalamic-amenorrhea. J Clin Endocrinol Metab 66:733–739, 1988
[PubMed]
 
Suter DE, Schwartz NB: Effects of glucocorticoids on secretion of luteinizing hormone and follicle-stimulating hormone by female rat pituitary cells in vitro. Endocrinology 117:849–854, 1985
[PubMed]
 
Tannenbaum GS, Ling N: The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 115:1952–1957, 1984
[PubMed]
 
Thomas GJ, Moore RY, Harvey JA, et al: Relations between the behavioral syndrome produced by lesions in the septal region of the forebrain and maze learning of the rat. J Comp Physiol Psychol 52:527–532, 1959
[PubMed]
 
Tilbrook AJ, Canny BJ, Stewart BJ, et al: Central administration of corticotrophin releasing hormone but not arginine vasopressin stimulates the secretion of luteinizing hormone in rams in the presence and absence of testosterone. J Endocrinol 162:301–311, 1999
[PubMed]
 
Uhde TW, Vittone BJ, Siever LJ, et al: Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry 21:1081–1085, 1986
[PubMed]
 
Uhde TW, Tancer ME, Black B, et al: Phenomenology and neurobiology of social phobia: comparison with panic disorder. J Clin Psychiatry 52 (suppl):31–40, 1991
 
Uhde TW, Tancer ME, Rubinow DR, et al: Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. Neuropsychopharmacology 6:101–118, 1992
[PubMed]
 
Uhde TW, Tancer ME, Gelernter CS, et al: Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers. J Affect Disord 30:155–161, 1994
[PubMed]
 
Unden F, Ljunggren JG, Beck-Friis J, et al: Hypothalamic-pituitary-gonadal axis in major depressive disorders. Acta Psychiatr Scand 78:138–146, 1988
[PubMed]
 
Valcavi R, Dieguez C, Page MD, et al: Alpha-2-adrenergic pathways release growth hormone via a non-GRF-dependent mechanism in normal human subjects. Clin Endocrinol (Oxf) 29:309–316, 1988
[PubMed]
 
Vance ML, Kaiser DL, Evans WS, et al: Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man. J Clin Endocrinol Metab 60:370–375, 1985
[PubMed]
 
Villanueva AL, Schlosser C, Hopper B, et al: Increased cortisol production in women runners. J Clin Endocrinol Metab 63:133–136, 1986
[PubMed]
 
Von Bardeleben U, Stalla GK, Muller OA, et al: Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment. Biol Psychiatry 24:782–786, 1988
 
Wiedemann K, Von Bardeleben U, Holsboer F: Influence of human corticotropin-releasing hormone and adrenocorticotropin upon spontaneous growth hormone secretion. Neuroendocrinology 54:462–468, 1991
[PubMed]
 
Williams CL, Nishihara M, Thalabard JC, et al: Corticotropin-releasing factor and gonadotropin-releasing hormone pulse generator activity in the rhesus monkey: electrophysiological studies. Neuroendocrinology 52:133–137, 1990
[PubMed]
 
Winokur A, Amsterdam J, Caroff S, et al: Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients. Am J Psychiatry 139:39–44, 1982
[PubMed]
 
Yehuda R: Current status of cortisol findings in post-traumatic stress disorder. Psychiatr Clin North Am 25:341–368, 2002
[PubMed]
 
Yehuda R, Kahana B, Schmeidler J, et al: Impact of cumulative lifetime trauma and recent stress on current posttraumatic stress disorder symptoms in holocaust survivors. Am J Psychiatry 152:1815–1818, 1995
[PubMed]
 
Yehuda R, Halligan SL, Grossman R, et al: The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biol Psychiatry 52:393–403, 2002
[PubMed]
 
Young EA, Breslau N: Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry 61:394–401, 2004a
 
Young EA, Breslau N: Saliva cortisol in posttraumatic stress disorder: a community epidemiologic study. Biol Psychiatry 56:205–209, 2004b
 
Young EA, Watson SJ, Kotun J, et al: Beta-lipotropin-beta-endorphin response to low-dose ovine corticotropin releasing factor in endogenous depression. Preliminary studies. Arch Gen Psychiatry 47:449–457, 1990
[PubMed]
 
Young EA, Haskett RF, Murphy-Weinberg V, et al: Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 48:693–699, 1991
[PubMed]
 
Young EA, Haskett RF, Grunhaus L, et al: Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry 51:701–707, 1994
[PubMed]
 
Young EA, Akil H, Haskett RF, et al: Evidence against changes in corticotroph CRF receptors in depressed patients. Biol Psychiatry 37:355–363, 1995
[PubMed]
 
Young EA, Lopez JF, Murphy-Weinberg V, et al: Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of corticotropin-releasing hormone secretion. Biol Psychiatry 41:1149–1155, 1997
[PubMed]
 
Young EA, Aggen SH, Prescott CA, et al: Similarity in saliva cortisol measures in monozygotic twins and the influence of past major depression. Biol Psychiatry 48:70–74, 2000a
 
Young EA, Midgley AR, Carlson NE, et al: Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Arch Gen Psychiatry 57:1157–1162, 2000b
 
Young EA, Carlson NE, Brown MB: Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 25:267–276, 2001
[PubMed]
 
Young EA, Tolman R, Witkowski K, et al: Salivary cortisol and posttraumatic stress disorder in a low-income community sample of women. Biol Psychiatry 55:621–626, 2004
[PubMed]
 
Zorn JR, Mathieson J, Risquez F, et al: Treatment of endometriosis with a delayed release preparation of the agonist D-Trp6-luteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients. Fertil Steril 53:401–406, 1990
[PubMed]
 
+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
All of the following findings have been reported in patients with depression except
2.
With regard to the hypothalamic-pituitary-adrenal (HPA) axis, which of the following has been reported in anxiety disorders?
3.
In patients with posttraumatic stress disorder (PTSD), which of the following findings has been reported?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 18.  >
Topic Collections
Psychiatric News
PubMed Articles
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation